Wellington Management Group’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Wellington Management Group’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-28,753	Closed	-$693K	–	2092
2023 Q1	$693K	Buy	+28,753	New	+$361K	﹤0.01%	1776

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Wellington Management Group's PRVB Position: Q2 2023 in Review

Wellington Management Group sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 28,753 shares — an estimated $693K sold.

Wellington Management Group first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $693K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Wellington Management Group reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Wellington Management Group sold 28,753 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $693K.
Wellington Management Group first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Wellington Management Group's Provention Bio, Inc. Common Stock position peaked at $693K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.